← Back to Search

Self-Management Program for Blood Cancer Survivors Post-Stem Cell Transplant (INSPIRE Trial)

Phase 3
Waitlist Available
Led By Karen Syrjala
Research Sponsored by Fred Hutchinson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Survival 2-5 years after last HCT when first approached for enrollment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

INSPIRE Trial Summary

This trial is testing a self-management program to help cancer survivors after stem cell transplant. The goal is to reduce stress and improve health care.

Who is the study for?
This trial is for adult cancer survivors who had a stem cell transplant to treat blood cancers, are in remission, and have survived 2-5 years post-transplant. Participants must be able to use the internet and email, speak English, and make their own healthcare decisions. Those with significant impairments or new invasive cancers (except skin cancer) within two years are excluded.Check my eligibility
What is being tested?
The study tests 'INSPIRE,' a self-management program along with a personalized survivorship care plan delivered via the internet, mobile app, and telehealth interventions. It aims to reduce stress and improve health care management for those recovering from stem cell transplants.See study design
What are the potential side effects?
Since this trial involves non-medical interventions like surveys and digital resources rather than drugs or medical procedures, traditional side effects aren't expected. However, participants may experience discomfort or fatigue from frequent engagement with the program.

INSPIRE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have survived for 2-5 years after your last hematopoietic stem cell transplant (HCT).

INSPIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cancer and Treatment Distress (CTXD)
HCA-cancer
Health Care Adherence (HCA)-cardio
Secondary outcome measures
Knowledge of survivorship needs
PHQ-8 Depression
PROMIS physical function
+2 more

INSPIRE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (INSPIRE, survivorship care plan)Experimental Treatment2 Interventions
Patients receive immediate access to the INSPIRE online program and personalized survivorship care plan.
Group II: Group II (usual care)Active Control2 Interventions
Patients receive an online program linking to existing online survivor resources and a personalized survivorship care plan. Patients may receive access to the INSPIRE online program after 12 months.

Find a Location

Who is running the clinical trial?

Fred Hutchinson Cancer CenterLead Sponsor
555 Previous Clinical Trials
1,334,184 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,606 Previous Clinical Trials
40,912,936 Total Patients Enrolled
1 Trials studying Blood Cancers
70 Patients Enrolled for Blood Cancers
Fred Hutchinson Cancer Research CenterLead Sponsor
443 Previous Clinical Trials
147,833 Total Patients Enrolled

Media Library

Self-Management Program and Survivorship Care Plan Clinical Trial Eligibility Overview. Trial Name: NCT03125070 — Phase 3
Blood Cancers Research Study Groups: Group I (INSPIRE, survivorship care plan), Group II (usual care)
Blood Cancers Clinical Trial 2023: Self-Management Program and Survivorship Care Plan Highlights & Side Effects. Trial Name: NCT03125070 — Phase 3
Self-Management Program and Survivorship Care Plan 2023 Treatment Timeline for Medical Study. Trial Name: NCT03125070 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you please tell us more about the potential risks of Survey Administration?

"There is some data to support the efficacy of Survey Administration and it has undergone multiple rounds of testing, so we feel confident in its safety rating it a 3."

Answered by AI

Are there any limitations on how many people can be enrolled in this research?

"In order to run this trial, 980 eligible patients are required. These individuals can be recruited from Loyola University Medical Center and Moffitt Cancer Center, which are located in Maywood, Illinois and Tampa, Florida respectively."

Answered by AI

Can new patients enroll in this clinical research project?

"The latest information from clinicaltrials.gov suggests that this trial is still open to new patients. The listing was first posted on November 5th 2020, with the 6/3/2022 update being the most recent available."

Answered by AI
~126 spots leftby Mar 2025